New Delhi:
The Serum Institute of India, the world’s largest vaccine maker, will begin stockpiling millions of doses of the Novavax coronavirus vaccine candidate beginning about April, CEO Adar Poonawalla told the Reuters Next conference on Thursday.
“Upwards of 40-50 million doses per month is what we are trying to stockpile starting from April,” he mentioned.
(Except for the headline, this story has not been edited by employees and is published from a syndicated feed.)